TY  - GEN
AU  - Kasahara,A
AU  - Hayashi,N
AU  - Mochizuki,K
AU  - Oshita,M
AU  - Katayama,K
AU  - Kato,M
AU  - Masuzawa,M
AU  - Yoshihara,H
AU  - Naito,M
AU  - Miyamoto,T
AU  - Inoue,A
AU  - Asai,A
AU  - Hijioka,T
AU  - Fusamoto,H
AU  - Kamada,T
TI  - Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response
SN  - 0168-8278
PY  - 1997///0605
KW  - Alanine Transaminase
KW  - blood
KW  - Antibodies, Viral
KW  - immunology
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Biomarkers
KW  - Chronic Disease
KW  - Collagenases
KW  - Female
KW  - Follow-Up Studies
KW  - Gelatinases
KW  - Genome, Viral
KW  - Glycoproteins
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C
KW  - enzymology
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Injections, Intravenous
KW  - Interferon-beta
KW  - Liver Cirrhosis
KW  - Male
KW  - Matrix Metalloproteinase 1
KW  - Matrix Metalloproteinase 2
KW  - Metalloendopeptidases
KW  - Middle Aged
KW  - Polymerase Chain Reaction
KW  - Protease Inhibitors
KW  - Proteins
KW  - metabolism
KW  - RNA, Viral
KW  - analysis
KW  - Tissue Inhibitor of Metalloproteinase-2
KW  - Tissue Inhibitor of Metalloproteinases
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1016/s0168-8278(97)80423-0
ER  -